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consistent method (Selcon) for estimating structures (30) , revealed mCRP to have 50-51% helix, 2-12% β-sheet, 20-23% β-turn and 12-20% random structure. These data indicate that a significant secondary structural change occurs when mCRP is formed from CRP, changing from predominantly β-sheet structure to an α-helical structure. A recombinant form of mCRP (r m CRP) with both cysteine residues mutated to alanine residues (i.e. C 36 A; C 97 A) and with an added N-terminal formyl-methionine residue was expressed in E. coli and was isolated from inclusion bodies to >95% purity (26). To enhance solubility, r m CRP was acylated with maleic anhydride or citraconic anhydride. Cysteine-mutated r m CRP was directly comparable to mCRP produced from (20) react with the same specificity and affinity to mCRP, r m CRP (33) , and acylated forms of r m CRP. Furthermore, preliminary experiments showed that , on a molar basis, mCRP and r m CRP and acylated forms of r m CRP produced similar delays in neutrophil apoptosis assessed by annexin-V and acridine orange staining (see below).
Therefore, because of the enhanced solubility and the similarity in biochemical characteristics, most results described in this report were obtained with maleic anhydride-acylated r m CRP. CRP peptides 77-82, 174-185 and 201-206 (purity >98%) were obtained from Sigma Chemical Co.
The endotoxin levels of CRP, mCRP, r m CRP and CRP peptide solutions were below the detection limit (0.125 EU/ml, corresponding to ~0.01 ng/ml Ec5) of the Limulus amebocyte lysate assay (E-Toxate, Sigma).
Isolation and culture of neutrophils -Neutrophils were isolated from venous blood of healthy volunteers (male and female, 22-48 years), who had not taken any drugs for at least 14 days before the experiments (15) . The protocol was approved by the Clinical Research Committee of the Maisonneuve-Rosemont Hospital. Neutrophils (5x10 6 cells/ml, purity >97%, viability >98%)
were resuspended in Hanks' balanced salt solution (HBSS) supplemented with 10% autologous plasma, and incubated with native or modified CRP or peptides derived from CRP in 0.5 ml conical polypropylene tubes on a rotator (Adams Nutator) at 37°C in 5% CO 2 . In additional experiments, neutrophils were preincubated with 50 µM PD98059, 2 µM wortmannin, 1 µM SB 7 stained nuclei) on a Leitz fluorescence microscope (34) . Standard cytospin preparations were stained with Wright-Giemsa dye for photographic demonstration of apoptotic morphologic features.
Quantification of apoptosis -Neutrophil apoptosis was quantitated as the percent of cells with hypodiploid DNA (35) and positive annexin-V staining (36) . Neutrophils (~10 6 ) were suspended in 0.5 ml hypotonic fluorochrome solution (50 µg/ml propidium iodide in 0.1% sodium citrate plus 0.1% Triton X-100) immediately before analysis. Propidium iodide fluorescence of individual nuclei was measured using a FACScan flow cytometer (Becton Dickinson). 10,000
events were acquired per sample. For specific annexin-V binding, neutrophils (10 6 ) were incubated in 100 µl binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl 2 , pH 7.4) containing a saturating concentration of phycoerythrin-labeled annexin-V for 15 min at 20°C and then washed with phosphate buffered saline before analysis by flow cytometry. Non-specific binding was determined by using calcium-free binding buffer (10 mM HEPES, 140 mM NaCl, 10 mM EDTA, pH 7.4).
DNA fragmentation -DNA cleavage was shown by quantification of fractional solubilized (low molecular weight) DNA by diphenylamine assay (37) and gel electrophoresis (34) . For the diphenylamine assay, data are reported as the percentage of soluble, low molecular weight DNA.
For DNA electrophoresis, DNA was extracted from neutrophils, precipitated and resuspended in Tris-EDTA buffer containing 25 µg/ml RNAse A (Roche), incubated for 5 min at 65ºC, and then subjected to electrophoresis in 0.8% agarose at 80 V for 70 min (34) . After staining with ethidium bromide, DNA was visualized by UV examination for image analysis. Modified CRP attenuates DNA fragmentation -Because DNA fragmentation is considered to be a hallmark of apoptosis, we performed a quantitative assay of DNA fragmentation. Neutrophils cultured for 24 hours showed a dramatic increase in the amount of low molecular weight DNA from a control value of 2% (in freshly isolated neutrophils) to 32% (P<0.01). Neutrophils cultured with mCRP showed marked decreases in the proportion of low molecular weight (soluble) DNA (Fig. 2f ). The effect of mCRP was concentration-dependent with an EC 50 value of 10 µg/ml. Electrophoretic analysis confirmed the ability of mCRP to inhibit DNA fragmentation in neutrophils (Fig. 2g ). The effect of 20 and 100 µg/ml mCRP was comparable to those of 1 µg/ml LPS (Fig. 2g) . Fig. 4a and b) . Phosphorylation of both ERK and Akt was rapid in onset, reaching a peak at around 2 min. The relative degree of ERK and Akt phosphorylation induced by formyl-Met-Leu-Phe (100 nM) is shown for comparison (Fig. 4b) . In vitro culture of neutrophils was associated with a sustained activation of p38 MAPK (Fig. 4c ).
mCRP delays neutrophil apoptosis through binding to FcγRIII (CD16)-
Enhanced p38 MAPK phosphorylation was detected as early as at 2 hours of culture, and was not blocked by either mCRP or LPS (Fig. 4c) .
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To assess the role of Akt, ERK and p38 MAPK in mCRP-affected neutrophil apoptosis, we used the selective MAPK/ERK kinase inhibitor PD98059, the PI 3-kinase (the upstream regulator of Akt activation) inhibitor wortmannin, and the p38 MAPK inhibitor SB 203580.
Neither PD98059, nor wortmannin alone affected development of neutrophil apoptosis, whereas SB 203580 significantly inhibited the percentage of annexin-V positive cells (P<0.01 compared to untreated control) and the percentage of neutrophils exhibiting hypodiploid nuclei (Fig. 4d) .
By contrast, both PD98059 and wortmannin effectively attenuated the inhibitory actions of mCRP, albeit complete reversal was never observed. The effects of PD98059 and wortmannin
were not additive (Fig. 4d) , indicating the mCRP effect is acting through a common downstream regulatory element. Combination of mCRP with SB 203580 did not result in greater degree of inhibition of neutrophil apoptotic features than those observed with mCRP or SB 203580 alone (Fig. 4d) .
Increased caspase-3 activity during neutrophil apoptosis and its inhibition by mCRP -Caspase-3 activity was barely detectable in freshly isolated neutrophils, whereas in vitro culture of neutrophils for 24 h induced significant increases in caspase-3 formation and activity (Fig. 5) .
Cleavage of pro-caspase-3 was confirmed by Western blotting, which also demonstrated a pronounced increase in the 17 kDa active form of caspase-3 (Fig. 5a ). Cleavage of pro-caspase-3
as well as caspase-3 activity were effectively reduced by mCRP in a concentration-dependent fashion ( Fig. 5a and 5b, respectively). PD98059 and wortmannin attenuated the caspase-3 inhibitory action of mCRP (Fig. 5c ). However, complete reversal was not achieved, not even with the combination of PD98059 and wortmannin.
DISCUSSION
Progression to apoptosis appears to be the normal default state for neutrophils, and cell survival is contingent upon rescue of cells from programmed cell death by signals from the environment. We describe in this report that a novel signal for delaying neutrophil apoptosis is the prototypical acute-phase reactant CRP. However, this action is "hidden" in native CRP, and is expressed only when the pentameric structure dissociates and undergoes a conformational rearrangement.
A growing body of evidence indicates that distinct species of CRP are formed during inflammation. Pentameric native CRP is synthesized and secreted mainly by hepatocytes into the blood (8, 9) . Pentameric CRP can be dissociated into free subunits through non-enzymatic (44) . Hence, the mCRP used in the present studies may be similar, if not identical to a naturally occurring isomeric form of CRP found in various tissues and cells throughout the body. 13 CRP and/or mCRP may be cleaved at one or more of three tuftsin-like (Thr-Lys-Pro-Arg) regions in CRP and mCRP, resulting in the release of biologically active peptides (45) . Interestingly, mCRP is more susceptible to proteolysis than is the native CRP molecule (46) .
In these studies we show that mCRP, but not native CRP or peptides derived from CRP, Several studies have reported the opposing effects of p38 MAPK and ERK or PI 3-kinase on apoptosis. In general, p38 MAPK appears to promote, while both ERK and PI 3-kinase appear to inhibit programmed cell death (47) (48) (49) (50) . Akt mediates the anti-apoptotic action of PI 3-kinase (51, 52) . Consistent with previous observations (48), our study also showed that spontaneous apoptosis in human neutrophils is associated with prolonged activation of p38 MAPK, and can be partially reversed by the specific p38 MAPK inhibitor SB203580. Activation of p38 MAPK then leads to cleavage of procaspase-3, yielding active caspase-3, one of the key effectors of apoptosis.
Incubation of neutrophils with mCRP led to rapid (within 1 to 2 min) and concentrationdependent activation of both ERK and Akt. In the present study, neither ERK nor PI 3-kinase inhibition could fully reverse mCRP-dependent inhibition of caspase-3 activation and delay the development of apoptotic morphology, suggesting an additional signaling mechanism at work. Constitutive neutrophil apoptosis is associated with activation of p38 MAPK and consequently caspase-3. In the presence of mCRP, a survival signaling pathway (through ERK and Akt) is activated, leading to inhibition of caspase-3 formation/activity and delay of apoptosis.
